When was Infinity Pharmaceuticals founded?

Infinity Pharmaceuticals was founded in 2001.

Where is Infinity Pharmaceuticals headquartered?

Infinity Pharmaceuticals is headquartered in Cambridge, Massachusetts, United States.

What industry is Infinity Pharmaceuticals in?

Infinity Pharmaceuticals operates in Biotech, Oncology.

How many employees does Infinity Pharmaceuticals have?

Infinity Pharmaceuticals has 11-50 employees.

Infinity Pharmaceuticals

Q: Who are Infinity Pharmaceuticals's investors?

Infinity Pharmaceuticals's investors include Biotechnology Value Fund, Advent Venture Partners, Venrock, Prospect Venture Partners.

Closed

Pioneering immuno-oncology through macrophage reprogramming

Public · Cambridge, United States · Founded 2001

Biotech

Oncology

Headquarters: Cambridge, Massachusetts
Employees: 11–50
Founded: 2001
Business Model: B2B

Website: infi.com
Last Round: Series AJun 2002
Rounds: 2
Type: Public

About

Infinity Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company focused on developing immuno-oncology therapies. Its lead candidate, eganelisib (IPI-549), is a potentially first-in-class, oral, once-daily selective inhibitor of PI3K-gamma that reprograms tumor-associated macrophages (M2 macrophages) to perform anti-tumor functions, thereby reducing immune suppression and encouraging immune activation. The company ran Phase 2 trials including MARIO-275 in urothelial cancer and MARIO-3 in triple-negative breast cancer. Infinity was listed on Nasdaq under ticker INFI and filed for Chapter 11 bankruptcy in October 2023.

Summary

Infinity Pharmaceuticals is a Biotech company based in Cambridge, United States, founded in 2001. Its most recent funding was a Series A round in Jun 2002. Investors include Biotechnology Value Fund, Advent Venture Partners and Venrock.